GlassScriptPhysician profile
Kevin Bruen
NPI 1427221886
$7,573.43
in general payments reported to CMS, 2019-2025
23 companies · $815 in 2025
The $815 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $492 · 2020: $33.69 · 2021: $698 · 2022: $2,378 · 2023: $2,791 · 2024: $366 · 2025: $815.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,803 · Travel and Lodging: $1,170.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,802.59 |
| Travel and Lodging | $1,169.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $2,504.04 | 2019-2025 | Gore Tag Thoracic Endoprosthesis, Gore Excluder Iliac Branch Endoprosthesis, Gore Tag Thoracic Branch Endoprosthesis |
| Endologix LLC | $1,796.62 | 2019-2024 | Alto Abdominal Stent Graft System, Ovation Ix Iliac Stent Graft, Torus Stent Graft System |
| Angiodynamics, INC. | $1,608.30 | 2022 | |
| Abbott Laboratories | $571.08 | 2019-2025 | Esprit, Xact, Diamondback Peripheral |
| Janssen Pharmaceuticals, INC | $165.40 | 2019-2024 | Xarelto |
| Lemaitre Vascular, INC. | $155.77 | 2023-2024 | Restoreflow, Artegraft Vascular Graft |
| Viz.Ai, INC. | $105.50 | 2022 | |
| Medtronic Vascular, INC. | $97.96 | 2019-2020 | |
| Chiesi USA, INC. | $80.00 | 2022 | |
| Cook Medical LLC | $74.49 | 2022-2024 | Zenith, Cook |
| E.R. Squibb & Sons, L.L.C. | $67.75 | 2023-2025 | Camzyos, Eliquis |
| Boston Scientific Corporation | $48.79 | 2025 | Avvigo Guidance System |
| Pfizer INC. | $45.52 | 2024-2025 | |
| Getinge USA Sales, LLC | $44.82 | 2021 | |
| Abiomed | $42.95 | 2025 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Recor Medical INC | $31.62 | 2024 | Paradise Renal Denervation System |
| Medtronic, INC. | $27.71 | 2023 | Endurant Iis |
| Horizon Therapeutics Plc | $21.49 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $19.63 | 2021 | |
| Asahi Intecc USA, INC. | $19.43 | 2022 | |
| Novartis Pharmaceuticals Corporation | $15.59 | 2022 | |
| Bard Peripheral Vascular, INC. | $14.50 | 2019 | |
| Philips North America LLC | $14.47 | 2025 | IV Other |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Bruen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.